Do Patient Group Directions (PGDs) prevent professionals getting non-medical prescribing qualifications? Are they now being used to manage planned care? Should they be retained and if so what changes could be made? Do they foster innovation and improvements in care? Are they bureaucratic? Are there other groups of health professionals who should be able to use PGDs? The Medicines and Healthcare products Regulatory Agency (MHRA) has launched an informal consultation about the provisions for PGDs in the NHS and private sector and other related matters and would like responses by 19 November. Revised guidance may accompany any new legislation, as the review offers the opportunity to look at this as well, and to clear up any misunderstandings.